Literature DB >> 17531565

Transmitted cytogenetic abnormalities in patients with mental retardation: pathogenic or normal variants?

Anne-Marie Bisgaard1, Maria Kirchhoff, Jens Erik Nielsen, Carsten Brandt, Hanne Hove, Birgit Jepsen, Tim Jensen, Reinhard Ullmann, Flemming Skovby.   

Abstract

Knowing the origin of cytogenetic abnormalities detected in individuals with mental retardation and dysmorphic features is essential to genetic counselling of affected families. To illustrate this, we report on six families with transmitted cytogenetic abnormalities and discuss the genotype-phenotype correlations, including the possibility of the abnormalities being normal genomic variants. The abnormalities were detected using metaphase HR-CGH; their size was estimated to range from 1.6 to 7.5 Mb using tiling path array-CGH and real-time PCR. The abnormalities were transmitted through two to four generations and included interstitial deletions of 1p31.3-p32.1, 2q13, 10q11.21-q11.23, and 13q31.1; a duplication of 1p34.1-p34.2; and in one family both a deletion of 18q21.1 and a duplication of 4q35.1-q35.2. The probands were mentally retarded and had nonspecific dysmorphic features except for one patient with the Bohring-Opitz syndrome. We considered the abnormalities in two families to be clinically significant: In one family, the proband's brain abnormality was comparable to previously reported abnormalities in individuals with a similar duplication of 1p31-p32. Congenital heart disease was previously mapped to the chromosomal region of 18q that was affected in the proband of another family. The carrier parents in both families had mild clinical features. In two families the abnormalities were considered as coincidental findings, and in two further families the abnormalities were insufficient to explain the phenotypes of the probands but possibly were related to a milder phenotype in other family members. These cases illustrate the need for careful assessment of the extended family in order to interpret the phenotypic consequences of abnormalities identified using array-CGH.

Entities:  

Mesh:

Year:  2007        PMID: 17531565     DOI: 10.1016/j.ejmg.2007.03.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  13 in total

1.  Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats.

Authors:  Paweł Stankiewicz; Shashikant Kulkarni; Avinash V Dharmadhikari; Srirangan Sampath; Samarth S Bhatt; Tamim H Shaikh; Zhilian Xia; Amber N Pursley; M Lance Cooper; Marwan Shinawi; Alex R Paciorkowski; Dorothy K Grange; Michael J Noetzel; Scott Saunders; Paul Simons; Marshall Summar; Brendan Lee; Fernando Scaglia; Florence Fellmann; Danielle Martinet; Jacques S Beckmann; Alexander Asamoah; Kathryn Platky; Susan Sparks; Ann S Martin; Suneeta Madan-Khetarpal; Jacqueline Hoover; Livija Medne; Carsten G Bonnemann; John B Moeschler; Stephanie E Vallee; Sumit Parikh; Polly Irwin; Victoria P Dalzell; Wendy E Smith; Valerie C Banks; David B Flannery; Carolyn M Lovell; Gary A Bellus; Kathryn Golden-Grant; Jerome L Gorski; Jennifer L Kussmann; Tracy L McGregor; Rizwan Hamid; Jean Pfotenhauer; Blake C Ballif; Chad A Shaw; Sung-Hae L Kang; Carlos A Bacino; Ankita Patel; Jill A Rosenfeld; Sau Wai Cheung; Lisa G Shaffer
Journal:  Hum Mutat       Date:  2011-11-02       Impact factor: 4.878

2.  Practical guidelines for interpreting copy number gains detected by high-resolution array in routine diagnostics.

Authors:  Nicolien M Hanemaaijer; Birgit Sikkema-Raddatz; Gerben van der Vries; Trijnie Dijkhuizen; Roel Hordijk; Anthonie J van Essen; Hermine E Veenstra-Knol; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Erica H Gerkes; Lamberta K Leegte; Klaas Kok; Richard J Sinke; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

3.  Segmental duplications mediate novel, clinically relevant chromosome rearrangements.

Authors:  M Katharine Rudd; Julia Keene; Brian Bunke; Erin B Kaminsky; Margaret P Adam; Jennifer G Mulle; David H Ledbetter; Christa L Martin
Journal:  Hum Mol Genet       Date:  2009-05-14       Impact factor: 6.150

4.  Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies.

Authors:  Elizabeth Goldmuntz; Prasuna Paluru; Joseph Glessner; Hakon Hakonarson; Jaclyn A Biegel; Peter S White; Xiaowu Gai; Tamim H Shaikh
Journal:  Congenit Heart Dis       Date:  2011-10-20       Impact factor: 2.007

5.  De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.

Authors:  Alexander Hoischen; Bregje W M van Bon; Benjamín Rodríguez-Santiago; Christian Gilissen; Lisenka E L M Vissers; Petra de Vries; Irene Janssen; Bart van Lier; Rob Hastings; Sarah F Smithson; Ruth Newbury-Ecob; Susanne Kjaergaard; Judith Goodship; Ruth McGowan; Deborah Bartholdi; Anita Rauch; Maarit Peippo; Jan M Cobben; Dagmar Wieczorek; Gabriele Gillessen-Kaesbach; Joris A Veltman; Han G Brunner; Bert B B A de Vries
Journal:  Nat Genet       Date:  2011-06-26       Impact factor: 38.330

6.  Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.

Authors:  Bianca Russell; Jennifer J Johnston; Leslie G Biesecker; Nancy Kramer; Angela Pickart; William Rhead; Wen-Hann Tan; Catherine A Brownstein; L Kate Clarkson; Amy Dobson; Avi Z Rosenberg; Samantha A Schrier Vergano; Benjamin M Helm; Rachel E Harrison; John M Graham
Journal:  Am J Med Genet A       Date:  2015-04-29       Impact factor: 2.802

Review 7.  Bohring-Opitz (Oberklaid-Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis.

Authors:  Rob Hastings; Jan-Maarten Cobben; Gabriele Gillessen-Kaesbach; Judith Goodship; Hanne Hove; Susanne Kjaergaard; Helena Kemp; Helen Kingston; Peter Lunt; Sahar Mansour; Ruth McGowan; Kay Metcalfe; Catherine Murdoch-Davis; Mary Ray; Marlène Rio; Sarah Smithson; John Tolmie; Peter Turnpenny; Bregje van Bon; Dagmar Wieczorek; Ruth Newbury-Ecob
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

8.  Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement?

Authors:  Susan G McGrew; Brittany R Peters; Julie A Crittendon; Jeremy Veenstra-Vanderweele
Journal:  J Autism Dev Disord       Date:  2012-08

9.  Investigation of 15q11-q13, 16p11.2 and 22q13 CNVs in autism spectrum disorder Brazilian individuals with and without epilepsy.

Authors:  Danielle P Moreira; Karina Griesi-Oliveira; Ana L Bossolani-Martins; Naila C V Lourenço; Vanessa N O Takahashi; Kátia M da Rocha; Eloisa S Moreira; Estevão Vadasz; Joanna Goes Castro Meira; Debora Bertola; Eoghan O'Halloran; Tiago R Magalhães; Agnes C Fett-Conte; Maria Rita Passos-Bueno
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

10.  A recurrent deletion on chromosome 2q13 is associated with developmental delay and mild facial dysmorphisms.

Authors:  Eva Hladilkova; Tuva Barøy; Madeleine Fannemel; Vladimira Vallova; Doriana Misceo; Vesna Bryn; Iva Slamova; Sarka Prasilova; Petr Kuglik; Eirik Frengen
Journal:  Mol Cytogenet       Date:  2015-07-31       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.